Home>
Stocks>
NGL Fine Chem Ltd

NGL Fine Chem Ltd (NGLFINE)

₹2515.6▲4.75%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

NGL Fine Chem Ltd share Performance

₹2482.35
₹2680
₹2515.6
1.32%
Low
Day's Volatility:7.86%
High
6.54%
₹1400
₹2823.9
₹2515.6
44.35%
Low
52 Weeks Volatility:56.60%
High
12.26%

Returns %
1 Month Return	23.2 %
3 Month Return	38.8 %
1 Year Return	83.27 %

Market Stats
Previous Close	₹2,640.95
Open	₹2,680.00
Volume	7,245.00
Upper Circuit	-
Lower Circuit	-
Market Cap	₹1,632.11Cr

Company Information

Established in 1981 in Maharashtra, the Company runs a registered office and factory in New Bombay. Mr. A.G Lawande and Mr. R.J Nachane are the promoters of the business that began by manufacturing Chloroquine Phosphate antimalarial. However, the adverse drought conditions in 1985-86 caused a dip in the demand for the drug, leading to a price war and resulting losses. The Company then faced an illegal strike from October 1996 till 1997. To continue operations they resorted to importing and having others process the materials. After resolving the labour disputes with the workers, the Company now looks to a brighter future.

Share Price: ₹2515.60 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹1,632.11Cr as of today
Revenue: ₹87.95Cr as on December 2023 (Q4 23)
Net Profit: ₹10.03Cr as on December 2023 (Q4 23)
Listing date: 08 Jul, 2022
Chairperson Name: Milind V Shinde

Organisation	NGL Fine Chem Ltd
Headquarters	Mumbai
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Key events for NGL Fine Chem Ltd

NGL Fine Chem Ltd's Stock Price Rises by 26% - 20 Apr, 2024
NGL Fine-Chem Limited's stock price has risen by an impressive 26% in the last month and 81% over the past year. However, its high P/E ratio of 41.4x compared to other Indian companies and recent earnings decline are concerning.
NGL Fine-Chem Stock Up by 31% in Last Three Months - 19 Apr, 2024
NGL Fine-Chem's stock has risen significantly over the last three months. An article analyzes the company's financial indicators, including ROE and earnings growth.

Fundamentals of NGL Fine Chem Ltd

Insights on NGL Fine Chem Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NGLFINE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 74.36 Cr → 91.63 Cr (in ₹), with an average increase of 9.9% per quarter
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.04% to 0.10% in Mar 2024 quarter
POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 26.90% to 27.16% in Mar 2024 quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, NGLFINE stock has moved up by 23.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 10.48 Cr → 10.03 Cr (in ₹), with an average decrease of 4.3% per quarter
NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 73.06% to 72.74% in Mar 2024 quarter